Articles tagged with Deleterious Mutations
A study from The University of Osaka reveals nearly half of patients with extracranial arteriovenous malformations carry mutations in the RAS/RAF/MAPK signaling pathway. These mutations were linked to abnormal vascular morphology and were frequently detected in younger female patients.
A new study shows that lowering EMC10 levels restores brain function and memory in models of 22q11.2 Deletion Syndrome. Reducing EMC10 activity also alleviates symptoms, including improved cognitive deficits and social memory performance.
The CRISPR tool was successfully used to correct a genetic defect in cells affected by chronic granulomatous disease. However, the repair process also introduced new genetic defects, highlighting the need for caution when using CRISPR technology in clinical settings.
A study on ruff (Calidris pugnax) found a surprisingly low mutation load in the supergene controlling male mating strategies, forcing a reevaluation of supergene evolution. The researchers propose two potential scenarios to resolve this paradox: recent acquisition of recessive lethality or introgression from another species.
Researchers link tobacco smoking to 'stop-gain mutations' that disable tumor-suppressing proteins, allowing abnormal cells to grow unchecked. Smoking's impact on DNA is linked to increased stop-gain mutations, complicating cancer diagnosis and treatment.
A new study found nearly half of Florida panther mutations originated from Texas and Central American pumas, bringing both good and bad genetic material. Researchers emphasize the need to monitor genetic health due to potential risks, especially with small population sizes. Genetic screening for future introductions may be necessary.
Researchers have discovered a selfish genetic element, known as Segregation Distorter (SD), that skews genetic inheritance. SD has caused dramatic changes in chromosome organization and genetic diversity, leading to the accumulation of deleterious mutations.
A study found that male animals have a greater genetic variance in reproductive success compared to females, which translates into purging deleterious mutations. This suggests that sexual selection on males bolsters adaptation and reduces the risk of extinction when facing challenging environmental conditions.
Despite 10,000 years of inbreeding, the kākāpō genome sequencing reveals that the species has lost potentially deleterious mutations and now carries fewer harmful mutations than extinct mainland populations. This finding suggests that natural selection may have facilitated genetic purging in small populations.
A new study from Uppsala University reveals that males play a crucial role in maintaining genetic health by eliminating harmful mutations. The research found that selective pressure on males leads to the purging of deleterious mutations, resulting in healthier genes and increased reproductive capacity.
A genomics study in Africa discovered that the genetic diversity and admixture of pygmies and Bantu-speaking farmers affected deleterious mutations. The researchers found similar burdens of mutations in both groups, despite different lifestyles.
A recent study published in Genome Biology and Evolution proposes that only 10-15% or up to 25% of the human genome is functional, with the remaining portion consisting of non-functional 'junk DNA'. This finding contradicts previous estimates suggesting 80% of the genome has a biochemical function.
A recent study found that mildly deleterious mutations evolve as neutral during early human migrations out of Africa, while very harmful mutations are found at similar frequencies globally. This suggests a maximum threshold for human tolerance to genetic damage.
Researchers found that a slow response to reduced fitness accelerates Muller's ratchet, increasing the frequency of clicks. Even in unfavorable conditions, a small proportion of positive mutations can sustain populations, explaining the long-term maintenance of mitochondria.
The study found significant variation in breast cancer risk among BRCA1 and BRCA2 carriers, with younger age at diagnosis associated with increased risk for relatives. The research highlights the need for accurate estimation of risks and tailored interventions.